Related Experiment Video
Updated: Sep 8, 2025

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.6K
Use of the Rash Appearance to Distinguish Cholinergic Urticaria Subtypes: A Retrospective Cohort Study
M Nagai1, T Fukumoto1, S Imamura1
1Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan.
American Journal of Clinical Dermatology
|July 27, 2025
Summary
Cholinergic urticaria (CholU) presents with varied rashes. Goosebump-like rashes, distinct from typical wheals, are linked to hypohidrosis and more common in males, suggesting distinct clinical subtypes.
Area of Science:
- Dermatology
- Immunology
- Allergy
Background:
- Cholinergic urticaria (CholU) is a hives condition triggered by heat, exercise, or stress.
- Classifying CholU by rash type is crucial for management, but understudied.
- This study explores rash morphology in CholU and its clinical associations.
Purpose of the Study:
- To investigate associations between CholU rash types and clinical phenotypes.
- To explore potential underlying mechanisms for different rash types in CholU.
Main Methods:
- Retrospective analysis of 64 CholU patients.
- Classification into red wheal/erythema (n=44) or goosebumps (n=20) groups.
- Evaluation of autologous sweat/serum skin tests, atopic dermatitis, and hypohidrosis.
Main Results:
- Goosebumps group: higher male proportion, hypohidrosis, and pain.
- Red wheal/erythema group: higher ASwST positivity, atopic dermatitis, and pruritus.
- Male sex significantly associated with goosebumps rash; hypohidrosis and pain also linked.
Conclusions:
- CholU patients exhibit diverse rashes, including goosebump-like eruptions.
- Goosebump-like rashes are associated with hypohidrosis and male sex.
- Rash type can aid in differentiating CholU clinical subtypes for targeted management.
Related Concept Videos
Allergic Reactions
28.5K
Overview
28.5K
Cholinergic Antagonists: Pharmacokinetics
558
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
558
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Allergic Drug Reactions
971
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
971
Cholinergic Receptors: Muscarinic
2.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.9K
Adrenergic Receptors: ɑ Subtype
1.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.7K

